Siga Technologies to supply mpox therapy in Morocco
Oct 8 (Reuters) - Drugmaker Siga Technologies SIGA.O said on Tuesday it would supply its therapy for mpox in Morocco, in response to a request from the country's health ministry for protection against any potential outbreak of the disease. (Reporting by Puyaan Singh in Bengaluru; Editing by Shilpi Majumdar) ((Puyaan.Singh@thomsonreuters.com;))
Recent news on SIGA Technologies
See all newsBrief: Siga Secures Contract Valued At Up To $15 Million From Canadian Department Of National Defence To Purchase Tpoxx®
SIGA Technologies Q2 revenue, profit drop as contract ends
SIGA Technologies Q1 revenue falls, net loss widens
Brief: SIGA Technologies Q1 EPS USD -0.05
Brief: EMA Recommends Restricting Use Of Tecovirimat SIGA